Welcome!

News Feed Item

US Personalized Cancer Genome Sequencing Market Outlook 2018

NEW YORK, March 18, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Personalized Cancer Genome Sequencing Market Outlook 2018
http://www.reportlinker.com/p02048459/US-Personalized-Cancer-Genome-Sequencing-Market-Outlook-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

The whole genome sequencing technology, over the past decade, has developed at an unprecedented rate. There has been a rapid progression from targeted gene sequencing to targeted whole genome sequencing coupled with bioinformatics based sequencing platforms to analyze the data and thereby impart personalized treatment to individuals. The Whole Genome Sequencing has proved to be a key to new breakthrough in fighting against cancer. The explosion of genomic data into personalized treatment of cancer is due to the development of new methods, and the exponential decline in cost of whole genome sequencing.

Our report entitled "US Personalized Cancer Genome Sequencing Market Outlook 2018" entails detailed study of current and future cancer prevalence and incidences across US. In addition, it provides an insight about the leading states with cancer incidences. Also covered is age wise statistics for cancer and comprehensive figures for cancer in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for growth. Besides, the report also provides potential customer base and the market's growth potential for personalized cancer WGS till 2018.

The said advanced technology has potential to revolutionize the field of medicine. We have closely monitored the regulatory landscape related to sequencing which requires consideration of the authorities over genome based tests. It has been observed that whole genome sequencing services have been concurrently regulated by FDA, CDC and CMS. Further, we have also discussed the various constraints faced by the industry players with suitable suggestions to overcome them. Apart from this, a major hurdle is to persuade health insurers to reimburse for the cost of sequencing the genomes of individual.

The report analyzes the competitive landscape of the market by properly analyzing the business, services and activities of the companies such as Illumina, Complete Genomics, and Ambry Genetics. It also provides the competitive benchmarking, taking into account key information such as market value, revenues, risk score etc., along with the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for clients who want to get an in-depth understanding of the market.
1. Analyst View
2. Research Methodology
3. Genome Sequencing: An Introduction
4. Cancer Statistics by Demographics
4.1 Prevalence, Incidences, and Mortality (2010-2018)
4.2 Leading States by Incidence
4.3 Leading Cancers by Incidence
4.3.1 Male Cancer Incidences
4.3.2 Female Cancer Incidences
4.3.3 Age-Group
5. US Personalized Cancer WGS Potential Market to 2018
6. US Personalized Cancer WGS: Current and Future Market Analysis
7. Regulatory Insights
7.1 Clinical Laboratory Improvement Amendments (CLIA) Accreditation
7.2 CAP Accreditation
8. Market Constraints
9. Competitive Assessment
9.1 Illumina
9.1.1 Business Overview
9.1.2 Key Information
9.1.3 Strengths and Weaknesses
9.2 Complete Genomics
9.2.1 Business Overview
9.2.2 Key Information
9.2.3 Strengths and Weaknesses
9.3 Beckman Coulter Genomics
9.3.1 Business Overview
9.3.2 Key Information
9.3.3 Strengths and Weaknesses
9.4 Expression Analysis
9.4.1 Business Overview
9.4.2 Key Information
9.4.3 Strengths and Weaknesses
9.5 EdgeBio
9.5.1 Business Overview
9.5.2 Key Information
9.5.3 Strengths and Weaknesses
9.6 Foundation Medicine
9.6.1 Business Overview
9.6.2 Key Information
9.6.3 Strengths and Weaknesses
9.7 SeqWright
9.7.1 Business Overview
9.7.2 Key Information
9.7.3 Strengths and Weaknesses
9.8 Ambry Genetics
9.8.1 Business Overview
9.8.2 Key Information
9.8.3 Strengths and Weaknesses
9.9 BGI Americas Corporation
9.9.1 Business Overview
9.9.2 Key Information
9.9.3 Strengths and Weaknesses
9.10 Cofactor Genomics
9.10.1 Business Overview
9.10.2 Key Information
9.10.3 Strengths and Weaknesses

List of Figures:

Figure 3-1: Schematic Diagram of Sequencing used for Human Genome Project
Figure 3-2: Long-range Sequence Assembly in Whole Genome Shotgun Sequencing
Figure 4-1: Cancer Prevalence (Million), 2010-2018
Figure 4-2: Cancer Incidences (Million), 2010-2018
Figure 4-3: Cancer Mortality ('000), 2010-2018
Figure 4-4: Incidences by Type of Cancer (%), 2014
Figure 4-5: Cancer Incidences by Age Group (%), 2010
Figure 5-1: Number of People earning > US$ 100K (2009-2012)
Figure 5-2: Potential Customers for Personalized Cancer WGS Market (Billion), 2013-2018
Figure 5-3: Potential Customers for Personalized Cancer WGS Market by Age-Group (%), 2014
Figure 5-4: Potential Market for Personalized Cancer WGS (Billion US$), 2013-2018
Figure 6-1: Tapped and Untapped Personalized Cancer WGS Market (%), 2014
Figure 6-2: Personalized Cancer WGS Market (Million US$), 2013-2018

List of Tables:

Table 4-1: Top Ten States with Highest Cancer Incidences ('000), 2014
Table 4-2: Top Ten Cancer Incidences in Males (2014)
Table 4-3: Top Ten Cancer Incidences in Females (2014)
Table 5-1: Top Ten States with Households earning > US$ 100K (2012)
Table 5-2: Key Demographics and Potential Customers for Personalized Cancer WGS Market (2014)
Table 5-3: Potential States for Personalized Cancer Whole Genome Sequencing
Table 9-1: Illumina - Key information
Table 9-2: Complete Genomics - Key Information
Table 9-3: Beckman Coulter Genomics - Key Information
Table 9-4: Expression Analysis - Key Information
Table 9-5: Edge Bio - Key Information
Table 9-6: Foundation Medicine - Key Information
Table 9-7: SeqWright - Key Information
Table 9-8: Ambry Genetics - Key Information
Table 9-9: BGI Americas Corporation - Key Information
Table 9-10: Cofactor Genomics - Key Information

To order this report: US Personalized Cancer Genome Sequencing Market Outlook 2018
http://www.reportlinker.com/p02048459/US-Personalized-Cancer-Genome-Sequencing-Market-Outlook-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
ChatOps is an emerging topic that has led to the wide availability of integrations between group chat and various other tools/platforms. Currently, HipChat is an extremely powerful collaboration platform due to the various ChatOps integrations that are available. However, DevOps automation can involve orchestration and complex workflows. In his session at @DevOpsSummit at 20th Cloud Expo, Himanshu Chhetri, CTO at Addteq, will cover practical examples and use cases such as self-provisioning infra...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, discussed how from store operations and ...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
Blockchain. A day doesn’t seem to go by without seeing articles and discussions about the technology. According to PwC executive Seamus Cushley, approximately $1.4B has been invested in blockchain just last year. In Gartner’s recent hype cycle for emerging technologies, blockchain is approaching the peak. It is considered by Gartner as one of the ‘Key platform-enabling technologies to track.’ While there is a lot of ‘hype vs reality’ discussions going on, there is no arguing that blockchain is b...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
The cloud era has reached the stage where it is no longer a question of whether a company should migrate, but when. Enterprises have embraced the outsourcing of where their various applications are stored and who manages them, saving significant investment along the way. Plus, the cloud has become a defining competitive edge. Companies that fail to successfully adapt risk failure. The media, of course, continues to extol the virtues of the cloud, including how easy it is to get there. Migrating...
The need for greater agility and scalability necessitated the digital transformation in the form of following equation: monolithic to microservices to serverless architecture (FaaS). To keep up with the cut-throat competition, the organisations need to update their technology stack to make software development their differentiating factor. Thus microservices architecture emerged as a potential method to provide development teams with greater flexibility and other advantages, such as the abili...
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
Leading companies, from the Global Fortune 500 to the smallest companies, are adopting hybrid cloud as the path to business advantage. Hybrid cloud depends on cloud services and on-premises infrastructure working in unison. Successful implementations require new levels of data mobility, enabled by an automated and seamless flow across on-premises and cloud resources. In his general session at 21st Cloud Expo, Greg Tevis, an IBM Storage Software Technical Strategist and Customer Solution Architec...
The use of containers by developers -- and now increasingly IT operators -- has grown from infatuation to deep and abiding love. But as with any long-term affair, the honeymoon soon leads to needing to live well together ... and maybe even getting some relationship help along the way. And so it goes with container orchestration and automation solutions, which are rapidly emerging as the means to maintain the bliss between rapid container adoption and broad container use among multiple cloud host...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across business networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost as well as advance trade. Are you curious about how Blockchain is built for business? In her session at 21st Cloud Expo, René Bostic, Technical VP of the IBM Cloud Unit in North America, discussed the b...